de Zeeuw R A, Herder R E, Wiechers J W, Drenth B F
Groningen Centre for Drug Research, Bioanalysis and Toxicology Group, University of Groningen, The Netherlands.
Pharm Res. 1990 Jun;7(6):638-43. doi: 10.1023/a:1015878430173.
Upon application of 14C-labeled cyoctol to the forearm of healthy volunteers, no parent cyoctol was detectable in ipsilateral blood plasma. The 14C activity was largely accounted for by a component with higher lipophilicity than the parent compound, as justified from their HPLC retention. Thus, this study suggests that human skin is capable of nearly complete cutaneous first-pass metabolism, resulting in negligible systemic availability of cyoctol. In a comparable experiment, rabbits were also able to convert cyoctol during skin absorption to a more lipophilic metabolite, which was identified as the palmitoleic acid ester of O-demethylated cyoctol by GC/MS. However, chromatographic evidence indicates that the human ipsilateral metabolite differs from the rabbit cyoctol metabolite.
将14C标记的赛洛多辛应用于健康志愿者的前臂后,在同侧血浆中未检测到母体赛洛多辛。14C活性主要由一种亲脂性高于母体化合物的成分所占据,这从它们的高效液相色谱保留情况得到了证实。因此,本研究表明人类皮肤能够进行几乎完全的皮肤首过代谢,导致赛洛多辛的全身可用性可忽略不计。在一项类似实验中,兔子在皮肤吸收过程中也能够将赛洛多辛转化为一种亲脂性更强的代谢物,通过气相色谱/质谱联用仪鉴定其为去甲基赛洛多辛的棕榈油酸酯。然而,色谱证据表明人类同侧代谢物与兔子的赛洛多辛代谢物不同。